Aspirin IV (Hyloris Pharmaceuticals)

N/A

Report date: 2024/03/22 11:34:56

Base Information

Drug NameAspirin IV (Hyloris Pharmaceuticals)
Drug Alias Nameintravenous aspirin (Hyloris Pharmaceuticals)intravenous acetylsalicylic acid (Hyloris Pharmaceuticals)HY 073HY-073HY-CVS-073 +[6] 
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsCoronary Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesHyloris Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesHyloris Pharmaceuticals SARhoshan Pharmaceuticals Inc
Inactive CompaniesHyloris Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsCoronary Disease

Other Information

ATC CodeN/A
Related LinksN/A